PROPHYLAXE VON KRANKHEITEN BEIM MULTIPLEN MYELOM - Prof. Hartmut Goldschmidt im Interview

People with multiple myeloma have an increased risk of infections and other related illnesses. Professor Hartmut Goldschmidt explains which preventative measures can protect patients. From vaccinations and avoiding sources of infection to the early detection of complications – the right prophylaxis can significantly improve quality of life and support the success of therapy. About the Association "Myelom-heilen e.V." is a non-profit organization in Germany specializing in supporting patients with multiple myeloma and their families. Founded in 2018, the association aims to improve the quality of life for myeloma patients and optimize their care. "Myelom-heilen e.V." offers a variety of support and information services, including self-help groups, online forums, and informational events. The association also regularly organizes meetings for patients and their families, as well as seminars and training courses. Myelom-heilen e.V. In addition, the association is committed to promoting research into the treatment of multiple myeloma and improving therapy options for those affected. The association works closely with physicians and scientists to foster innovative treatment approaches and support the transfer of knowledge between patients and professionals. Furthermore, the association is an important resource for people living with multiple myeloma. It offers support, information, and a sense of community for patients and their families and advocates for the needs and interests of myeloma patients to be heard in the public sphere. About the person Hartmut Goldschmidt is a German oncologist and hematologist who is a professor at the Department of Internal Medicine V at Heidelberg University Hospital. He specializes in the treatment of patients with multiple myeloma, a cancer that affects the bone marrow. Professor Goldschmidt has conducted and published numerous clinical studies to develop better treatment options for patients with multiple myeloma. He is a member of several national and international professional societies and has received various awards for his work. Professor Goldschmidt is also an experienced stem cell transplantation expert and has published numerous scientific papers on this topic. Furthermore, he is actively involved in the training of young doctors and researchers in the fields of oncology and hematology.